Immune responses in advanced colorectal cancer following repeated intradermal vaccination with the anti-CEA murine monoclonal antibody, PR1A3: results of a phase I study.
BACKGROUND AND AIMS: The aim was to determine the toxicity, clinical and immune responses to the murine monoclonal anti-carcinoembryonic antigen (CEA) antibody, PR1A3, in patients with advanced colorectal cancer. MATERIALS AND METHODS: Fifteen patients with advanced colorectal cancer received eithe...
প্রধান লেখক: | Zbar, A, Thomas, H, Wilkinson, R, Wadhwa, M, Syrigos, K, Ross, E, Dilger, P, Allen-Mersh, T, Kmiot, W, Epenetos, A, Snary, D, Bodmer, W |
---|---|
বিন্যাস: | Journal article |
ভাষা: | English |
প্রকাশিত: |
2005
|
অনুরূপ উপাদানগুলি
অনুরূপ উপাদানগুলি
-
CEA-targeted monoclonal antibody therapy in colorectal cancer
অনুযায়ী: Conaghan, P, অন্যান্য
প্রকাশিত: (2009) -
Reply: In vitro and in vivo anticancer efficacy of unconjugated humanised anti-CEA monoclonal antibodies
অনুযায়ী: Ashraf, S, অন্যান্য
প্রকাশিত: (2008) -
Antibody targeting studies in a transgenic murine model of spontaneous colorectal tumors.
অনুযায়ী: Wilkinson, R, অন্যান্য
প্রকাশিত: (2001) -
CEA monitoring in colorectal cancer is not a waste of time.
অনুযায়ী: Mant, D, অন্যান্য
প্রকাশিত: (2014) -
Optimization of serum free medium for the production of humanized anti-cea monoclonal antibody.
অনুযায়ী: Ab Latif, Nurzila
প্রকাশিত: (2011)